The clinical trial testing the efficacy of the oral HIV antiretroviral drug, Truvada, was terminated in South Africa yesterday. External analysis by the Independent Data Monitoring Committee determined there was no detectable decrease in HIV transmission rate between those receiving Truvada and those who did not.

continue reading